Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 94 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Other Revenues $ 0 $ 0 $ 431,461
Operating expenses:      
General and administrative expenses 523,443 161,974 4,185,484
Research and development expenses 257,233 0 1,123,906
Total operating expenses 780,676 161,974 5,309,390
Operating loss (780,676) (161,974) (4,877,929)
Other (expense) income:      
Interest expense (27,765) (42,981) (616,361)
Other income 0 0 53,978
Total other expense (27,765) (42,981) (562,383)
Net loss $ (808,441) $ (204,955) $ (5,440,312)
Net loss per common share basic and diluted $ (0.01) $ (0.04)  
Weighted average number of shares outstanding 60,145,237 5,645,212